Wehrmann T, Stergiou N, Schmitt T, Dietrich C F, Seifert H
Dept. of Internal Medicine I, Academic Hospital of Hanover-Siloah, Roesebeckstrasse 15, 30449 Hanover, Germany.
Endoscopy. 2003 Jun;35(6):472-7. doi: 10.1055/s-2003-39677.
Endoscopic microtransducer manometry of the sphincter of Oddi has been shown to be a reliable alternative to perfusion manometry for evaluating sphincter of Oddi motor function. It avoids volume loading of the biliopancreatic system, and may therefore be associated with a lower risk of inducing postmanometry pancreatitis.[nl]
During a 2-year period, microtransducer manometry of the sphincter of Oddi was carried out in 215 patients (median age 42 years; 155 women; biliary study in 152 cases, additional pancreatic evaluation in 63 cases). Sphincter of Oddi manometry was conducted as the sole procedure in all patients. The frequency of pancreatitis was assessed prospectively and graded according to established guidelines. A total of 130 consecutive patients (median age 37 years, 92 women; 30 with biliary type II, 58 with type III, 34 with pancreatic type I, and eight with type II) were then randomly assigned to undergo microtransducer or perfusion manometry of the sphincter of Oddi in a standardized fashion.
During the initial 2-year period, nine cases of pancreatitis (a pancreatitis frequency of 4.2 %) were observed after microtransducer manometry, and most were of mild degree (six mild, two moderate, and one severe). No deaths occurred, and no surgical procedures were required. In the randomized part of the study, the demographic and clinical characteristics of the patients in both groups, as well as the technical aspects of the procedures performed, were well matched. The frequency of pancreatitis after microtransducer manometry was 3.1 %, compared with 13.8 % after perfusion manometry ( P < 0.05). Pancreatitis occurred in two patients after microtransducer manometry, and was mild in both cases. After perfusion manometry, mild pancreatitis occurred in six patients and moderate pancreatitis in three.
Endoscopic microtransducer manometry of the sphincter of Oddi is associated with a lower risk for postmanometry pancreatitis than standard perfusion manometry.
已证明,内镜下Oddi括约肌微传感器测压是评估Oddi括约肌运动功能的可靠方法,可替代灌注测压法。它避免了胆胰系统的容量负荷,因此可能与测压后胰腺炎的较低风险相关。[荷兰语]
在2年期间,对215例患者(中位年龄42岁;155例女性;152例进行胆道研究,63例进行额外的胰腺评估)进行了Oddi括约肌微传感器测压。所有患者均将Oddi括约肌测压作为唯一的检查方法。前瞻性评估胰腺炎的发生率,并根据既定指南进行分级。然后,将130例连续患者(中位年龄37岁,92例女性;30例为胆道II型,58例为III型,34例为胰腺I型,8例为II型)随机分配,以标准化方式接受Oddi括约肌微传感器或灌注测压。
在最初的2年期间,微传感器测压后观察到9例胰腺炎(胰腺炎发生率为4.2%),大多数为轻度(6例轻度,2例中度,1例重度)。无死亡病例,无需进行外科手术。在研究的随机部分,两组患者的人口统计学和临床特征以及所进行检查的技术方面均匹配良好。微传感器测压后胰腺炎的发生率为3.1%,而灌注测压后为13.8%(P<0.05)。微传感器测压后有2例患者发生胰腺炎,均为轻度。灌注测压后,6例患者发生轻度胰腺炎,3例发生中度胰腺炎。
与标准灌注测压相比,内镜下Oddi括约肌微传感器测压后胰腺炎的风险较低。